Analysis of antigen processing in melanoma cells, its influence on the success of cancer vaccination and enhancement in a combined-immunotherapy xenograft model of melanoma

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1007381

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer vaccines, an exciting new treatment option that aims to boost a patientÍs own immune system to fight a growing cancer, have shown great promise in developmental studies. Although these vaccines generate strong anti-cancer responses in the blood of treated patients, less than expected results have been observed in terms of increased patient survival. This project aims to understand how the cancer escapes recognition by the immune system and ways to enhance the effects of cancer vaccines.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $297,891.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Tumour Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell epitope | antibody cancer therapy | antigen processing | cancer immunotherapy | cancer vaccine | melanoma

Related Links